Main outcome measures were the rate of IV thrombolytic therapy, initial
National Institutes of Health Stroke Scale (NIHSS) score, door-to-needle time (ie, time from the patient’s arrival in the emergency department to initiation of intravenous
rt-PA), onset-to-treatment time (OTT), intracerebral hemorrhage, and morbidity and mortality at 3 months.